These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
380 related items for PubMed ID: 32097248
1. Therapeutic Drug Monitoring Coupled With Bayesian Forecasting Could Prevent Vancomycin-Associated Nephrotoxicity in Renal Insufficiency Patients: A Prospective Study and Pharmacoeconomic Analysis. Zhang Y, Wang T, Zhang D, You H, Dong Y, Liu Y, Du Q, Sun D, Zhang T, Dong Y. Ther Drug Monit; 2020 Aug; 42(4):600-609. PubMed ID: 32097248 [Abstract] [Full Text] [Related]
2. Reduced nephrotoxicity with vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against a trough 15-20 μg/mL concentration. Oda K, Jono H, Nosaka K, Saito H. Int J Antimicrob Agents; 2020 Oct; 56(4):106109. PubMed ID: 32721597 [Abstract] [Full Text] [Related]
3. Clinical application of vancomycin TDM in ventilated patients with gastrointestinal cancer: a propensity-matched analysis. Zhang X, Wu Y, Wang D. BMC Infect Dis; 2024 Jan 02; 24(1):10. PubMed ID: 38166695 [Abstract] [Full Text] [Related]
4. TDM coupled with Bayesian forecasting should be considered an invaluable tool for optimizing vancomycin daily exposure in unstable critically ill patients. Pea F, Bertolissi M, Di Silvestre A, Poz D, Giordano F, Furlanut M. Int J Antimicrob Agents; 2002 Nov 02; 20(5):326-32. PubMed ID: 12431867 [Abstract] [Full Text] [Related]
7. Determination of a vancomycin nephrotoxicity threshold and assessment of target attainment in hematology patients. Wong S, Selby PR, Reuter SE. Pharmacol Res Perspect; 2024 Aug 02; 12(4):e1231. PubMed ID: 38940223 [Abstract] [Full Text] [Related]
11. Economic impact of aminoglycoside toxicity and its prevention through therapeutic drug monitoring. Slaughter RL, Cappelletty DM. Pharmacoeconomics; 1998 Oct 02; 14(4):385-94. PubMed ID: 10344906 [Abstract] [Full Text] [Related]
12. Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis. Ye ZK, Tang HL, Zhai SD. PLoS One; 2013 Oct 02; 8(10):e77169. PubMed ID: 24204764 [Abstract] [Full Text] [Related]
15. [Level of evidence for therapeutic drug monitoring of vancomycin]. Jelassi ML, Benlmouden A, Lefeuvre S, Mainardi JL, Billaud EM, Groupe Suivi Therapeutique Pharmacologique de la Societe Francaise de Pharmacologie et de Therapeutique. Therapie; 2011 Oct 02; 66(1):29-37. PubMed ID: 21466775 [Abstract] [Full Text] [Related]
17. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center. Meng L, Wong T, Huang S, Mui E, Nguyen V, Espinosa G, Desai J, Holubar M, Deresinski S. Pharmacotherapy; 2019 Apr 02; 39(4):433-442. PubMed ID: 30739349 [Abstract] [Full Text] [Related]
19. Should the trough concentration of vancomycin be abandoned in therapeutic drug monitoring? A multicentre, retrospective study of critically ill patients without any form of dialysis. Yu Z, Liu J, Yu H, Zhou L, Zhao Y, Zhong L, Zhu J, Liang G, Yang Y, Zheng Y, Yu L, Han G. Int J Antimicrob Agents; 2023 Jun 02; 61(6):106812. PubMed ID: 37037321 [Abstract] [Full Text] [Related]
20. A Prospective Multicenter Clinical Observational Study on Vancomycin Efficiency and Safety With Therapeutic Drug Monitoring. Liang X, Fan Y, Yang M, Zhang J, Wu J, Yu J, Tao J, Lu G, Zhang H, Wang R, Wen X, Li H, Zhang F, Hang J, Shen L, Zhang Z, Lin Q, Fu F, Wu S, Shen B, Huang W, Chang C, Zhang H, Huang Q, Shi Y, Ren H, Yuan Q, Song X, Luo X, Zhang H. Clin Infect Dis; 2018 Nov 13; 67(suppl_2):S249-S255. PubMed ID: 30423040 [Abstract] [Full Text] [Related] Page: [Next] [New Search]